Category Archives: Industry: Healthcare

Healthcare is an ever evolving industry, and field. These Press Releases, will keep you up to date on the newest, greatest, best, solutions available.

Industry: Healthcare

RCare announces corporate expansion, names Nick Garofoli as Operations Manager

Leave a comment


Nick Garofoli, Niels Coch, Kaiser Clipston, Navy Keith

New RCare executive team members

“Our number one goal is to provide a comprehensive and interoperable suite of capabilities and services to improve the lives of our clients and those they serve,” said Myron Kowal, CEO of RCare. “We needed to build up our team to achieve these milestones.”


WEBSTER, N.Y. (PRWEB)

In response to an increased demand for its advanced monitoring and nurse call technologies, RCare, Inc., announced today a series of initiatives to support the company expansion. After moving to a larger corporate facility, RCare has rounded out the team with four new executive team members and has also recently expanded their nurse call monitoring suite by unveiling three brand new products.

To lead the change and support the product expansion, RCare has brought on a new Operations Manager. With a diverse background leading organizations of varied types and sizes, Nick Garofoli is a Lean Six Sigma Black Belt and ADKAR trained. He has a proven track record of helping organizations identify opportunities and mitigate risk. “I’m excited to be joining a local, community-oriented company with international impact,” says Garofoli. “I’m looking forward to supporting RCare in day-to-day operations while improving the RCare experience for our clients.”

RCare was seeking a seasoned business development and sales manager to support the North and South American marketplaces. With nearly 15 years of global sales experience and over a decade in healthcare technology, Niels Coch fit the bill. Coch will cultivate new and existing relationships throughout the healthcare space for existing and emerging RCare technologies.

To continue their leadership in emerging technology products and services, RCare has also welcomed Kaiser Clipston and Nathaniel “Navy” Keith to the Product Support Engineering team. With a BS in Computer Science from The College at Brockport, Clipston enjoys working on business projects, mobile development, game design, and music production. With experience in technical support and troubleshooting, Keith has a BS in Computer Information Systems from SUNY and has a background in sales and relationship marketing.

“It’s an exciting period of growth for RCare,” said Myron Kowal, CEO of RCare. “Our number one goal is to provide a comprehensive and interoperable suite of capabilities and services to improve the lives of our clients and those they serve. We needed to build up our team to achieve these milestones.”

In addition to new staff, RCare has unveiled 3 new product offerings: A new interoperable wired nurse call solution, a full line of Inovonics products, and a new system designed and priced for affordable housing programs.

RCare has introduced the iCall system, the company’s latest full-IP wired nurse call technology. Communities can customize wired nurse call solutions, wireless or a hybrid of both. Now even wired campuses can benefit from RCare’s advanced analytics and rich reporting tools along with powerful data to support the organization’s compliance and quality improvement efforts.

“Allowing for seamless interoperability between wired and wireless solutions was necessary for communities looking to benefit from the latest in nurse call innovation,” said Kowal. “They can even save on upfront costs by using existing hardware and still optimize with RCare’s analytics and reporting technologies.”

To ensure affordability, RCare is now an authorized reseller of Inovonics products for new and existing call system installations. Companies choosing RCare’s state-of-the-art nurse call system can now use new or existing Inovonics hardware for upfront cost savings.

“Our mission is to improve the lives of all seniors and those who care for them,” emphasized Kowal. “In order to accomplish this, we decided to make an even lower cost solution to accommodate affordable housing providers.”

RCare created the HCube, an emergency call program for affordable housing communities. The program has an incredibly low cost of entry and nominal ongoing fees. It requires minimal hardware to maintain, no landlines, and only one internet connection for the entire building.

Things are moving quickly for RCare. They will celebrate their growth at the upcoming AHCA/NCAL show October 13-16 in Orlando, FL and the LeadingAge Annual conference October 27-30 in San Diego.

ABOUT RCare

RCare is a global provider of wireless nurse call and personal emergency response systems for the entire spectrum of eldercare and senior living. Our components integrate into a variety of healthcare communication systems to create efficient and verifiable responses to medical emergencies. RCare works together with distribution partners to build individualized, flexible and seamless systems to enhance both caregiving and resident quality of life. Contact info@rcareinc.com or call 585-671-4144.

Share article on social media or email:

Industry: Healthcare

3Lions Publishing, Inc. Announces Release 2.5 of Expresso®: Breach Notification Wizard

Leave a comment


https://www.prweb.com/

Online Publishing Done Right!

What QBO did for accounting Expresso® 2.5 does for Risk Assessments and Breach Notification. Transforming these processes into something that a business person can master at some basic to intermediate level.


TAMPA, Fla. (PRWEB)

3Lions Publishing, Inc. (3LP), the owner/operator of the HIPAA Survival Guide, is pleased to announce Release 2.5 of Expresso® featuring our Breach Notification Wizard. Expresso® 2.5 is available for purchase on the HIPAA Survival Guide Store as part of our HIPAA Compliance Subscription Plan. Expresso® is our software-as-a-service offering which embodies the NIST seven (7) step process for performing Risk Assessments and is now poised to save our customers hundreds of person hours by identifying when Breach Notification is triggered and gathering the requisite information necessary to Notify stakeholders under applicable Federal/State law.

Our Wizard contains a Jurisdictions table that enables you to quickly determine the Notification requirements of all U.S. States/Territories that may have been impacted by the Breach. It also performs the necessary “Notification math” that determines when HHS is notified, depending on how many patients were impacted across Jurisdictions and when “major media” is notified, depending on how many patients were impacted within a Jurisdiction.

Carlos Leyva, CEO of 3Lions Publishing, Inc., says: “What QuickBooks Online (“QBO”) did for accounting Expresso® 2.5 does for Risk Assessments and Breach Notification. QBO did not eliminate all the work associated with accounting, however it transformed accounting from a necessary evil, something to be avoided at all costs and/or handed over to a third party, to something that a business person could master at some basic to intermediate level. With the Release of Expresso® 2.5 3Lions continues to deliver on the promise of Enterprise Compliance for the Masses.”

Covered entities no longer need to fear willful neglect for lack of visible, demonstrable evidence of a Risk Assessment. Further, our Wizard, together with our Breach Notification Framework and our Breach Response Framework, will save your organization tens of thousands of dollars when (not if) your organization experiences a Breach. Although Expresso® does not completely obviate the need for counsel, it will save you hundreds of person-hours of billable time.

About 3Lions Publishing, Inc. (3LP)

3LP focuses on publishing online curated content within well-defined subject matter domains, such as healthcare. 3LP helps publishers leverage and monetize their content by providing a publishing platform that matches high quality content with a digital marketing centric set of audience development tools. 3LP is located in the greater Tampa, FL area.

Share article on social media or email:

Industry: Healthcare

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Leave a comment


Drs. Shipra Gandhi and Pawel Kalinski will lead a Department of Defense-funded clinical trial assessing a three-pronged immunotherapy strategy for metastatic breast cancer.

Drs. Shipra Gandhi and Pawel Kalinski will lead a Department of Defense-funded clinical trial assessing a three-pronged immunotherapy strategy for metastatic breast cancer.

Our strategy uses a unique combination of biologic agents to make tumors visible to the immune system by making them look like tissue that’s been infected by a virus. Findings from earlier studies lend strong support for assessing this combination even in aggressive and hard-to-treat cancer types.


BUFFALO, N.Y. (PRWEB)

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense (DoD) grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center. The four-year, $6.42 million Breakthrough Award (award no. W81XWH-19-1-0674/BC180510) through the DoD’s Breast Cancer Research Program will fund a clinical trial in patients with brain-metastatic breast cancer, to be led by Shipra Gandhi, MD, Assistant Professor of Oncology in the Department of Medicine at Roswell Park.

The phase II trial, slated to open in 2020, would be the first clinical study to assess the effectiveness of a three-pronged strategy combining distinct immunotherapy approaches:


  • A new dendritic-cell treatment vaccine developed by Dr. Kalinski and colleagues in collaboration with Brian Czerniecki, MD, PhD, Chair of the Breast Oncology Department at Moffitt Cancer Center in Tampa, Florida

  • Chemokine modulation using a combination proposed and validated by Dr. Kalinski as an optimized adjuvant for dendritic-cell vaccines, incorporating rintatolimod (brand name Ampligen) and interferon alfa-2b (brand name Intron A)

  • Immune checkpoint inhibition

Alone, these therapies are effective for a limited number of patients, but evidence suggests that together they may help break through a persistent challenge in oncology: how to turn “cold” tumors that don’t respond to existing therapies into “hot” ones that the immune system can be trained to recognize and pursue.

“A major limitation of cancer immunotherapy is that tumors adapt to naturally occurring effector cells by shutting down production of the relevant chemokines in the tumor microenvironment,” says Dr. Kalinski, the overall Principal Investigator for the project. “Our strategy uses a unique combination of biologic agents to make tumors visible to the immune system by making them look like tissue that’s been infected by a virus. We’ve never tested them all together before in patients, but the findings from earlier clinical and preclinical studies lend strong support for assessing this combination even in the most aggressive and hard-to-treat cancer types.”

Three key factors distinguish this platform for combination immunotherapy:

  • The approach is tumor-selective, meaning it can act preferentially to generate responses only in cancer tissues, but not in normal, noncancerous tissue

  • It selectively activates so-called “good” chemokines in the tumor microenvironment and promotes selective attraction of desirable tumor-fighting immune cells, but avoids activating “bad” chemokines that attract undesirable suppressive cells

  • These therapies have been shown in preclinical and clinical trials to be associated with low toxicity and few adverse side effects

The team will study this approach first in patients with localized brain-metastatic breast cancer (BMBC), or breast cancer that has begun to spread to the brain but is not yet widely disseminated. A companion clinical trial in patients with disseminated, leptomeningeal BMBC, to be led by Peter A. Forsyth, MD, Chair of the Neuro-Oncology Department at Moffitt Cancer Center, in collaboration with Dr. Czerniecki, partnering Principal Investigator on the project, will move forward with additional DoD funding of more than $8 million. Both trials will be available to patients at Roswell Park and at Moffitt.

“There are currently no curative treatments for breast cancer that has spread to and grown in the brain, and the options we have often involve significant side effects or harm to healthy tissues. So this is an area of pronounced clinical need,” notes Dr. Gandhi, Principal Investigator on the Roswell Park study. “We’re particularly encouraged to be developing a strategy that has the potential to be effective for patients with various breast cancer subtypes — cancers that are positive for HER2 markers as well as notoriously aggressive triple-negative breast cancers.”

Roswell Park has three other studies in progress assessing some of the component elements of this new therapeutic platform:

  • Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients with Colorectal Cancer Metastatic to the Liver (NCT03403634 – actively recruiting)

  • Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients with Prostate Cancer Before Surgery (NCT NCT03899987 – authorized by the FDA and Roswell Park’s Internal Review Board; not yet recruiting)

  • Chemokine Modulation Therapy and Pembrolizumab in Treating Participants with Metastatic Triple-Negative Breast Cancer (NCT NCT03599453 – actively recruiting)

AIM ImmunoTech Inc. has agreed to provide rintatolimod for the new DoD-funded studies in brain-metastatic breast cancer, as well as these ongoing studies.

Dr. Kalinski gratefully acknowledges earlier support for his work through donations to Roswell Park as a critical foundation that allowed him to pursue and attract outside funding for this work.

The new study in patients with BMBC is not yet open to accrual. For information about other clinical trials currently available at Roswell Park, please visit roswellpark.org/clinical-trials, call 1-800-ROSWELL (1-800-767-9355) or contact Roswell Park by email at askroswell@roswellpark.org.

This release is also available on the Roswell Park website: https://www.roswellpark.org/media/news/roswell-park-moving-unique-immunotherapy-platform-forward-642-million-dod-grant

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

Share article on social media or email:

Industry: Healthcare

eClinical Solutions’ Dawn Kaminski Serves as Co-Chair again for SCDM 2019

Leave a comment


elluminate Data Central is reducing the time spent on data review and reconciliation activities by 30%, said Diane Lacroix, Director of Data Management at eClinical Solutions.


BOSTON (PRWEB)

As leaders in the clinical data management industry, eClinical Solutions team members were selected to participate in SCDM 2019 as the co-chair, session leaders and expert speakers. Hosted annually by the Society of Clinical Data Management, SCDM is the world’s premier data management conference and brings together 70 speakers to discuss data management advances and technologies that are driving clinical trials and regulatory standards. The 2019 SCDM Annual Meeting will take place in Baltimore, Maryland from September 29 to October 2.

“Data management is core to our business, which is why SCDM is so important to us,” says Katrina Rice, eClinical Solutions’ Executive Vice President of Professional Services. “It is essential to give the life sciences industry the right tools for accurate and timely data review and management. We are extremely proud to be involved in this world-class event.”

The eClinical Solutions team will be participating in a variety of thought leadership sessions, as well as a product showcase.

Clinical Data Management 2022, with Dawn Kaminski, Amy Nordo (Pfizer), Drew Garty (Veeva Systems) and session chair Dan Crawford (Veeva Systems), will explore areas where technology will have the greatest impact: data workbenches, integration of EDC and risk based monitoring, and eSource. Artificial Intelligence to Solve Clinical’s “Big Data” Challenges will bring together leaders in clinical data technology innovation, including eClinical Solutions’s CTO, Sam Anwar, eClinical Solutions’s CEO, Raj Indupuri, Catherine Celingant (Pfizer) and Jason Raines (Apellis) for a discussion on opportunities for data management transformation leveraging AI and machine learning. Diane Lacroix will chair a session on An Agile Approach to Data Management: Improving the End-to-End Clinical Data Strategy and will be joined by Julie Savoia, eClinical’s Manager of Data Management & Training, Professional Services, as well as Cecilia Calcagno (PRA Health Sciences) and Elizabeth Thompson (Sarepta Therapeutics). Finally, eClinical Solutions’s CEO, Raj Indupuri, and Chief Marketing Officer, Sheila Rocchio, will speak on how digital data strategies are being designed and implemented across R&D organizations during Roadmap to D-Clinical along with Deborah Lucas (Ra Pharmaceuticals) and Chris Jennings (Triverus Consulting). More information can be found on the SCDM conference website.

The product showcase will focus on the elluminate®️ platform and elluminate Data Central which is enabling next generation data review and management. Data managers use elluminate Data Central to view and manage all their clinical data from numerous sources and to automate formerly manual data review processes. The product showcase will highlight how elluminate Data Central is being used by data managers and medical monitors for incremental data review, query, issue and workflow management and for comprehensive data and medical review using interactive visual patient profiles.

“elluminate Data Central is reducing the time spent on data review and reconciliation activities by 30%,” said Diane Lacroix, Director of Data Management at eClinical Solutions. “We are excited about showcasing these new capabilities and providing use cases and examples to data managers about how this product can help increase productivity and improve overall data quality.”

Details:

Session 1 – Clinical Data Management 2022: A Glimpse Into the Future with Dawn Kaminski | Monday, September 30, 2019, 11:15 AM-12:15 PM

Session 9 – Roadmap to D-Clinical – Designing Your Digital Data Strategy with Raj Indupuri and Sheila Rocchio | Monday, September 30, 2019: 4:00 PM-5:30 PM

Session 6 – Artificial Intelligence to Solve Clinical’s “Big Data” Challenges with Raj Indupuri and Sam Anwar | Tuesday, October 1, 2019, 1:30 PM-3:00 PM

Session 17 – An Agile Approach to Data Management: Improving the End-to-End Clinical Data Strategy with Diane Lacroix and Julie Savoia | Tuesday, October 1, 11:30 AM – 12:30 PM

elluminate®️ Product Showcase | Tuesday, October 1, 9:30 AM-10:15 PM

About eClinical Solutions

eClinical Solutions is a leading provider of cloud based enterprise software and software-driven clinical data services. The elluminate® platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies on more than 500 trials. For more information, visit http://www.eclinicalsol.com.

Share article on social media or email:

Industry: Healthcare

AlayaCare Offers Deepest Integration to Medicaid Billing Through Partnership with Waystar Claims Management Solution

Leave a comment



TORONTO (PRWEB)

AlayaCare, a leading home care software provider, today announced the deepest Medicaid billing integration of its kind through a partnership with Waystar’s claims management solution. With this integration, home care agencies can increase operational efficiency and improve revenue performance, while remaining focused on providing quality care and improving patient outcomes.

“Billing, payment and claim management – these are important and complex functions for any home care agency particularly when the process is manual and paper-based,” said Neil Grunberg, VP Product, AlayaCare. “We offer a fully integrated electronic billing solution that simplifies the process. It streamlines workflows, improves staff productivity, and can mean higher claims revenue for agencies.”

AlayaCare, a cloud-based home healthcare platform for home and community care agencies, has fully integrated its electronic billing capabilities with Waystar’s revenue cycle technology. Waystar offers the industry’s highest-rated client service to more than 450,000 providers, 22,000 healthcare organizations and 750 health systems and hospitals.

“As a longtime partner of AlayaCare, Waystar is excited to help further simplify the revenue cycle and maximize revenue opportunities for home care agencies through this new integration,” said Matt Hawkins, Waystar CEO. “In a world of constantly changing reimbursement rules, providers need intelligent technology to help them get ahead of denials, reduce cost to collect, and bring in more revenue—so they can focus their resources on ever-better patient care.”

AlayaCare’s integration with Waystar facilitates a seamless claims process between providers and insurance payers. With Waystar, AlayaCare clients can pre-screen for claim errors, check insurance eligibility and consolidate and manage their electronic claims from a single location. This greatly simplifies the process, particularly when managing rejected claims. The electronic billing solution allows clients to make any needed corrections and re-submit within the software suite.

Electronic billing can help agencies maximize reimbursement, and in jurisdictions where banking is permitted, agencies can use the built-in tool to track partial hours to ensure that they receive funding for actual time spent providing care.

“There are agencies that are losing money because they aren’t tracking quarter or half units. They’re paying their caregivers, because the service was provided, but not billing for the time,” said Grunberg. “We appreciate that banking is not permitted in all states, but in places where it is, we want to help our clients maximize their revenue in the simplest, most efficient way.”

For more information about AlayaCare’s electronic billing capabilities and the value it offers to clients, visit the AlayaCare website here: http://www.alayacare.com

About AlayaCare

AlayaCare’s unique platform includes Back Office, Client and Family Portals, Remote Patient Monitoring, Telehealth, and Mobile Care Worker functionality in one integrated, highly robust and secure, cloud-based system. AlayaCare is providing the platform for Home and Community Care organizations to propel towards innovation and home care of the future. AlayaCare was founded in 2014. http://www.alayacare.com

About Waystar

Waystar provides next-generation, cloud-based technology that simplifies and unifies the healthcare revenue cycle. The Waystar platform removes friction in payment processes, streamlines workflows and improves financials for providers in every care setting. Waystar has scored Best in KLAS® every year since 2010 and earned multiple #1 rankings from Black Book™ surveys since 2012. The Waystar platform supports more than 450,000 providers, 750 health systems and hospitals, and 5,000 payers and health plans. For more information, visit waystar.com or follow @Waystar on Twitter.

For more information:

AlayaCare Media Enquiries: Amy Cole, amy@colecomms.ca, 647-287-0025

AlayaCare Client Enquiries: Brady Murphy, VP, Sales & Marketing, 647-477-4174 ext. 201

Share article on social media or email:

Industry: Healthcare

Virsys12 Selected as a Venture Atlanta 2019 Presenting Company

Leave a comment



ATLANTA (PRWEB)

Virsys12 announced on Monday that it has been chosen out of hundreds of applicants as one of the top 36 rising star technology companies in the Southeast that will present on stage at Venture Atlanta 2019. The 12th annual Venture Atlanta, the Southeast’s premier event for connecting technology innovation and investment capital, will be held October 16-17 in the heart of downtown Atlanta. With representation of over 200 national investor funds and an expected attendance of over 1,000 technology entrepreneurs, premier investors and key executives from across the country, Venture Atlanta has served as a launching pad for hundreds of companies over the past 12 years, connecting them with game-changing capital and opportunities to drive significant growth.

“We are honored to be selected to share the Virsys12 story of growth, transformational technologies and solutions for healthcare built on Salesforce at Venture Atlanta” said Tammy Hawes, Founder and CEO of Virsys12.

Virsys12 is a Salesforce AppExchange and Gold partner offering healthcare apps (V12 Network and V12 IPD “Intelligent Provider Directory”) and solutions that focus on the management of provider networks, contracts, and compliance for payers and health systems utilizing Salesforce Health Cloud and Heroku.

“With over $4.3 billion in funding awarded to date, Venture Atlanta has become the authority for recognizing technology innovation across the largest footprint in the Southeast, connecting the region’s best and brightest innovators with top-tier investors and other leaders in our technology ecosystem,” said Allyson Eman, executive director of Venture Atlanta. “This year, with over one-third of the presenting companies coming from outside Georgia, we’re thrilled to be showcasing the largest lineup yet, from emerging technologies to venture-stage companies that reflect our region’s incredible people, our innovation and continued opportunities for growth.”

During the two-day event, presenting companies and conference attendees will engage with regional as well as national venture capitalists, investors and other key players in the current technology landscape. The conference results in funding, national investor exposure and invaluable relationship-building with successful technology executives. In addition to hearing from the 36 presenting companies and lineup of over a dozen expert speakers, attendees will have an opportunity to network with over 40 selected Venture Atlanta “startup showcase companies” to watch that represent the most exciting emerging technologies in the Southeast. These innovators will be highlighted with dedicated tables at the conference to provide sneak peeks into their plans and products. Atlanta-based independent investment management firm, Invesco, is this year’s premier sponsor. Techstars will help kick off the conference on October 14 with Techstars Atlanta 2019 Demo Day in partnership with Cox Enterprises.

To learn more about Virsys12, visit http://www.virsys12.com. For additional information about Venture Atlanta, to register for the event or to view the conference schedule, please visit http://www.ventureatlanta.org.

About Venture Atlanta

Venture Atlanta, the Southeast’s technology innovation event, is where the region’s most promising tech companies meet the country’s top-tier investors. As the Southeast’s largest investor showcase helping launch more than 350 companies and raise over $4.3 billion in funding to date, Venture Atlanta connects the region’s top entrepreneurs with local and national venture capitalists, bankers, angel investors and others in the technology ecosystem who can help them raise the capital they need to grow their businesses. The annual nonprofit event is a collaboration of three leading Georgia business organizations: Atlanta CEO Council, Metro Atlanta Chamber and the Technology Association of Georgia (TAG). For more information, visit http://www.ventureatlanta.org. For updates, follow us on Twitter and visit our blog.

About Virsys12

Virsys12 is a healthcare technology company utilizing the Salesforce platform to provide scalable, flexible, and secure cloud-based solutions for payers and providers nationally. As a Salesforce AppExchange and Gold consulting partner, Virsys12 provides transformational healthcare solutions to meet the changing regulatory, reimbursement, and patient consumer trends within the industry. For more information, visit https://www.virsys12.com.

Share article on social media or email:

Industry: Healthcare

Fire Equipment Manufacturers’ Association Releases Whitepaper on Pressure-Reducing Valves

Leave a comment


Understanding how pressure-reducing valves work and how they are regulated is key to keeping buildings safe. It will also help fire protection engineers and building owners select and adjust their PRVs, which is why the information contained in this newly released whitepaper is so valuable.


CLEVELAND (PRWEB)

Fire Equipment Manufacturers’ Association just released a new whitepaper entitled ‘The Ins & Outs of Pressure-Reducing Valves’. The non-profit trade association encourages building managers and fire protection engineers to download and read the whitepaper to learn more about PRV standards and operation instructions.

Most high-rise projects are required by regulations to have automatic sprinkler systems as well as standpipe systems for use by fire departments. In such buildings, installing pressure-reducing valves on each floor can ensure that the pump pressure on the lower floors does not exceed standards established by the National Fire Protection Association while still allowing the minimum acceptable pressure to the top floors. The whitepaper released by Fire Equipment Manufacturer’s Association spells out the requirements and standards for PRVs.

“Understanding how pressure-reducing valves work and how they are regulated is key to keeping buildings safe. It will also help fire protection engineers and building owners select and adjust their PRVs, which is why the information contained in this newly released whitepaper is so valuable,” said Jeff Saunders, president of Fire Equipment Manufacturers’ Association. The whitepaper is based on a previously-written article the association updated with current information and is being published with permission from the original author.

Building managers, fire protection engineers and other interested parties are invited to read, study and download the whitepaper at https://femalifesafety.org/prv-whitepaper.html. Additional information about Fire Equipment Manufacturers’ Association can be found at https://femalifesafety.org/.

About the Fire Equipment Manufacturers’ Association

The Fire Equipment Manufacturers’ Association is a more than 80-year-old international non-profit trade association dedicated to saving lives and protecting property by providing education of a balanced fire protection design. For additional information, including videos, interactive questionnaires and training websites about fire safety and protection, visit http://www.femalifesafety.org or call 216-241-7333. For a complete listing of member companies, visit the Member Profiles page of the association’s website at http://www.femalifesafety.org/membership.html.

Share article on social media or email:

Industry: Healthcare

Comfort Your V Naturally with Heating and Cooling ‘Private Packs’

Leave a comment


We give you choices - Hot or Cold Vulva Pads

Heating or Cooling Pick Your Pack

Private Packs intends to start the conversation about vulvovaginal self-care by first honoring vulvas in a natural, therapeutic way.


BROOKLYN, N.Y. (PRWEB)

Private Packs, an emerging women’s wellness company announces the launch of a set of natural, non-invasive heating and cooling pads used to soothe and comfort vulvas from myriad medical and beauty issues, or anytime a woman wants extra care of her vulva.

Women all over the world at one point have experienced vaginal discomfort, with as many as 14 million women in the United States experiencing chronic vulva pain as a result of vulvodynia. Rather than using bulky electric heating pads or shoving frozen vegetables down there, Private Packs is completely reimagining the outdated do-it-yourself solutions that women have been using for decades to get vulva relief. The brand’s food-grade therapy pads are wearable, discreet and reusable for life on-the-go.

“I created Private Packs for myself after a traumatic Brazilian wax. I then became a customer of my own product after stage three breast cancer treatment affected my vagina, which my doctors had not prepared me for,” said Suzanne Sinatra, founder, and chief executive officer of Private Packs. “Since it’s helped me so much I won’t stop until I get this product in the hands of women across the country. Women make up half of the global market and it’s high time we have an attractive alternative to vaginal discomfort.”

According to a March 2019 report from Frost & Sullivan, the Femtech industry is predicted to have a market potential of $50 billion by 2025 and will grow significantly as a result of continued innovation in the space.

“Private Packs addresses many vaginal issues women face, but having a reusable cooling pad that can be used immediately after childbirth for swelling and discomfort is a gamechanger for the approximately 90 percent of women who experience vaginal tearing,” said Dr. Kameelah Phillips, M.D. “Private Packs has integrated feedback from users and physicians to create a unique self-care experience for women unlike anything currently available on the market.”

Private Packs heating pads provide thermal therapy to relieve muscle pain/spasms, soreness, inflammation for relaxing relief. The cooling pads offer cryotherapy treatment that can reduce swelling, bruising, irritation and are refreshing. The products provide treatment options for women experiencing discomfort as a result of menstrual cramps, chronic infections, exercise soreness, post-surgery, pubic area hair removal, sexual activity or vaginal childbirth.

“Patients benefit from heat and ice to relieve their symptoms, so Private Packs is a great option for a variety of issues, but in particular, it fills the need for a non-medical alternative to pelvic floor pain and discomfort,” said Dr. Rachel Gelman, PT, DPT, Doctor of Physical Therapy and Pelvic Floor Specialist in San Francisco.

Private Packs launched today an Indiegogo campaign to raise money for additional inventory to meet the growing demand for its product. To learn more about the crowdfunding campaign, visit http://bit.ly/indiegogopp.

About Private Packs

Private Packs is a New York City-based women’s wellness company and the maker of heating and cooling gel pads optimized for both form and function to soothe and comfort the intimate body parts. The natural, safe and non-invasive gel pads comfort women that suffer from symptoms such as swelling, itching, inflammation, soreness and more related to Bacterial vaginosis (BV) sexually transmitted infections (STI), yeast infections, vaginal dryness, vaginal childbirth, post-sex, dyspareunia, pubic area hair removal, or anytime a woman wants extra care for her vagina. For more information, visit http://www.privatepacks.com.

Share article on social media or email:

Industry: Healthcare

Leading Bellevue Medspa A-to-Zen Cosmetic Surgery & Aesthetics Expands Menu With SkinPen® Microneedling in Bellevue, WA

Leave a comment


Microneedling is a proven skin rejuvenation treatment that uses tiny needles to revitalize skin and prompt new collagen growth for a wide range of complexion improvements.


BELLEVUE, Wash. (PRWEB)

A-to-Zen Cosmetic Surgery & Aesthetics, a leading medical spa in Bellevue, WA offering the highest level of both plastic surgery and non-surgical aesthetic treatments, has expanded its menu with SkinPen® microneedling, the world’s first FDA-cleared microneedling device. Microneedling is a proven skin rejuvenation treatment that uses tiny needles to revitalize skin and prompt new collagen growth for a wide range of complexion improvements. Microneedling helps to brighten and smooth skin, reduce pore size, diminish lines and wrinkles, fade scarring, reveal more even tone, and much more.

Microneedling pairs perfectly with other skin rejuvenation therapies, such as platelet-rich plasma (PRP) and chemical peels, for a synergistic boost of skin renewal.

Double board-certified Dr. John Bullis, owner, medical director and cosmetic surgeon of A-to-Zen Cosmetic Surgery & Aesthetics, along with his expert beauty team, will help you design the optimal treatment plan to meet your unique complexion needs and goals during your personal consultation.

In addition to microneedling, Dr. Bullis proudly offers a leading menu of surgical, non-surgical aesthetic, and body contouring treatments — from Botox® to tummy tucks — to help patients achieve their cosmetic goals with ease. To learn more about A-to-Zen Cosmetic Surgery & Aesthetics, please call 425.615.6307 to schedule a personal consultation today.

About A-to-Zen Cosmetic Surgery & Aesthetics

A-to-Zen Cosmetic Surgery & Aesthetics comprises a team of dedicated medical professionals who are committed to helping you look and feel your absolute best for total body vitality. Offering a holistic approach, A-to-Zen’s mission is to maximize the quality of life for patients by offering a blend of traditional and alternative medicine and a comprehensive range of both surgical and non-surgical treatments, including platelet-rich plasma (PRP) facial rejuvenation, PRP hair restoration, PRP for sexual health, PRP-enhanced fat transfer, truSculpt® 3D non-invasive fat removal, liposuction, breast augmentation, tummy tuck, labiaplasty, IV hydration therapy, Botox®, dermal fillers, ThermiVa® non-surgical vaginal rejuvenation, Sculpsure® non-invasive fat reduction, ThermiSmooth® non-invasive skin tightening, bio-identical hormone replacement therapy, medically-supervised weight loss, chemical peels, facials, acne treatments, and more.

About Dr. John Bullis

Owner and medical director of A-to-Zen Cosmetic Surgery & Aesthetics, Dr. John Bullis is board-certified by the American Board of Obstetrics and Gynecology (ABOG) and the American Board of Cosmetic Surgery (ABCS). Dr. Bullis has performed thousands of cosmetic surgical procedures and is an expert at both surgical and non-surgical body sculpting. An acclaimed cosmetic surgeon, Dr. Bullis uses advanced techniques to deliver optimal results with minimal discomfort and downtime. For example, he performs “Weekend Tummy Tucks” when appropriate using the Avelar Technique, which involves smoothing and flattening the belly without separating skin from muscle, a process that minimizes trauma to the body while dramatically enhancing the patient experience.

Dr. Bullis attended undergraduate and medical school at Georgetown University and obtained a Master’s Degree in physiology at the University of Maryland at Baltimore. Dr. Bullis served in the U.S. Army at Ft. Lewis, Washington, Fort Belvoir, Virginia, and Walter Reed Army Medical Center, in Washington, D.C., where he honed his surgical skills and specialized in urogynecology, pelvic reconstructive surgery, and minimally invasive gynecologic surgery.

Dr. Bullis is a Fellow of the American Academy of Cosmetic Surgeons (AACS), the American Congress of Obstetricians and Gynecologists (ACOG), the American Academy of Anti-Aging Medicine (A4M), the American Urogynecologic Society (AUGS), and the Obesity Medicine Association (OMA).

Share article on social media or email:

Industry: Healthcare

CNY Cosmetic & Reconstructive Surgery in East Syracuse, NY, to Hold Open House Celebration for Being Named a Top SkinCeuticals® by L’Oréal Flagship Provider

Leave a comment


The Beauty Team at CNY Cosmetic and Reconstructive Surgery understands that medical-grade skincare is the cornerstone for every results-driven skincare regimen.


SYRACUSE, N.Y. (PRWEB)

Board certified plastic surgeons Drs. Anthony Deboni and Gregory Baum are proud to announce that they are an official flagship provider for SkinCeuticals® by L’Oréal, a top-selling medical-grade skincare line. As a flagship provider, CNY Cosmetic & Reconstructive Surgery is a leading national provider of SkinCeuticals professional-grade skincare products.

To celebrate, CNY Cosmetic & Reconstructive Surgery is holding a special open house on September 26th, from 5:30-8:30 p.m., featuring exclusive discounts, giveaways, raffle prizes, light refreshments, and a special visit from a SkinCeuticals representative. To RSVP to the SkinCeuticals Flagship celebration, please call (315) 663-0112 today.

SkinCeuticals describes itself as “advanced skincare backed by science” and has received years of glowing reviews and professional acclaim for its results-driven formulations. From antioxidant-packed vitamin C serums, which offer “30 years of science in every bottle,” to anti-aging retinol and radiance-boosting exfoliators, SkinCeuticals is committed to helping people achieve their healthiest, most luminous complexion at every age and stage of life.

The Beauty Team at CNY Cosmetic and Reconstructive Surgery understands that medical-grade skincare is the cornerstone for every results-driven skincare regimen, and they work diligently with every patient to select the ideal SkinCeuticals products to meet their unique skin concerns and goals. What’s more, SkinCeuticals skincare is formulated to work synergistically with professional skin rejuvenation treatments, providing patients the ability to enhance and maintain their best results in the comfort of their own homes, between medical spa visits.

In addition to the distinction of being named a flagship provider, CNY Cosmetic & Reconstructive Surgery is introducing an online store for patients and consumers to purchase SkinCeuticals products with greater convenience.

To learn more about SkinCeuticals medical-grade skincare, or to RSVP for the celebration at CNY Cosmetic & Reconstructive Surgery on September 26th, please call (315) 663-0112 or click here to schedule a consultation today!

About CNY Cosmetic & Reconstructive Surgery

You can trust CNY Cosmetic & Reconstructive Surgery for the highest standard of excellence in cosmetic surgery and one of the most comprehensive selections of procedures and aesthetic treatments in Central New York. Led by board-certified plastic surgeons Drs. Baum and Deboni, thousands of satisfied patients have received the widely acclaimed and highly personalized care of CNY Cosmetic & Reconstructive Surgery.

Drs. Deboni and Baum are two of the most highly respected and trusted plastic surgeons in Central New York. Both attended medical school at the SUNY Health Science Center in Syracuse, where they also completed their general surgery training. They traveled to well-respected universities to complete their plastic surgery training and brought that training, knowledge, and experience back to Central New York. With years of surgical experience, they are well-versed in the most effective and leading cosmetic techniques.

CNY Cosmetic & Reconstructive Surgery offers both surgical and non-surgical procedures to help patients achieve their cosmetic goals, including Botox®, dermal fillers, laser skin rejuvenation, laser hair removal, FDA-cleared BodyTite and FaceTite, PRP Hair Restoration, and much more.

About Dr. Anthony Deboni

Dr. Deboni is a leading expert in cosmetic and reconstructive surgery with particular interest and experience in aesthetic surgery of the breast and body contouring. His notable accomplishments include board certification with the American Board of Plastic Surgery, membership with the American Society of Plastic Surgeons, clinical instructor of surgery at Upstate University Hospital in Syracuse, New York, and clinical instructor of otolaryngology at Upstate University Hospital in Syracuse.

Dr. Deboni is a recognized leader in breast and body cosmetic surgery. He came to Syracuse in 1998 and quickly established his expertise in breast surgery, being the first to perform the microsurgical TRAM flap breast reconstruction procedure. Dr. Deboni rapidly became known as a regional expert in breast and cosmetic surgery, and was invited to speak at several regional and national conferences. In 1997, he was the first in the area to be awarded appointment to the National Advisory Council for Leaders in Breast Aesthetics (NOVO) and was invited by Allergan Medical to advise on advancing the science in breast aesthetics.

About Dr. Gregory Baum

Dr. Baum is a recognized expert in both cosmetic and reconstructive surgery with an emphasis on breast surgery. His noteworthy accomplishments include board-certification by the American Board of Plastic Surgery, chief of plastic surgery at St. Joseph’s Hospital in Syracuse, New York, clinical instructor of surgery at University Hospital in Syracuse, and membership with the American Society of Plastic Surgeons.

Dr. Baum has lectured extensively throughout Central New York on topics in cosmetic surgery, breast reconstruction, skin cancer treatment, and skincare. He was appointed to the advisory panel for SkinCeuticals® by L’Oreal in 2012 and was appointed to the National Advisory Council for Leaders in Breast Aesthetics in 2012 by Allergan®. He was sought after for his advice in advancing the science of breast aesthetics; participation in this national forum is by invitation only and is based on overall excellence in plastic surgery and a commitment to superior outcomes.

Share article on social media or email: